Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01537536
What this trial is testing

Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Jules Bordet Institute 18
Not applicableActive Not RecruitingNCT05056844
What this trial is testing

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 40
Not applicableStudy completedNCT00343434
What this trial is testing

Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight

Who this might be right for
Breast CancerObesity
Wake Forest University Health Sciences 25
Early research (Phase 1)UnknownNCT02500199
What this trial is testing

Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors

Who this might be right for
Breast CancerGastric CancerSolid Tumors+1 more
Hengrui Therapeutics, Inc. 50
Not applicableStudy completedNCT00535509
What this trial is testing

Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 285
Testing effectiveness (Phase 2)Study completedNCT01506609
What this trial is testing

Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AbbVie 294
Testing effectiveness (Phase 2)Active Not RecruitingNCT02546232
What this trial is testing

Improved Breast Cancer Therapy (I-BCT-1) in the Neoadjuvant and Metastatic Setting

Who this might be right for
Breast Cancer
Oslo University Hospital 196
Not applicableLooking for participantsNCT07133087
What this trial is testing

Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors

Who this might be right for
Breast Cancer Female
Halic University 42
Large-scale testing (Phase 3)Study completedNCT01712893
What this trial is testing

Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 216
Not applicableStudy completedNCT01775514
What this trial is testing

A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics

Who this might be right for
Cancer
Hoffmann-La Roche 32,277
Not applicableEnrolling By InvitationNCT06793306
What this trial is testing

A Study Comparing the Differences Between Young and Non-young Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 3,000
Not applicableLooking for participantsNCT07539038
What this trial is testing

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Who this might be right for
Breast Cancer
Centro di Riferimento Oncologico - Aviano 44
Large-scale testing (Phase 3)Looking for participantsNCT06214195
What this trial is testing

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Who this might be right for
Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital 276
Not applicableEnded earlyNCT01103128
What this trial is testing

Validation of a Mouse Model of Pancreatic Carcinogenesis

Who this might be right for
Pancreatic Cancer
Columbia University 450
Testing effectiveness (Phase 2)Ended earlyNCT04460430
What this trial is testing

Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SOLTI Breast Cancer Research Group 12
Large-scale testing (Phase 3)Looking for participantsNCT05860465
What this trial is testing

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd 254
Not applicableNot Yet RecruitingNCT06787807
What this trial is testing

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Who this might be right for
ObesityColon CancerThyroid Cancer+14 more
Universidade Federal de Pernambuco 103
Testing effectiveness (Phase 2)Study completedNCT03703492
What this trial is testing

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ - Category
University of Wisconsin, Madison 12
Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Not applicableLooking for participantsNCT05977036
What this trial is testing

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

Who this might be right for
Metastatic Breast CancerUnresectable Breast Cancer
Washington University School of Medicine 65
Next Page